Home/Filings/4/0000914190-19-000506
4//SEC Filing

Gwydir Tom 4

Accession 0000914190-19-000506

CIK 0001196298other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:12 PM ET

Size

9.1 KB

Accession

0000914190-19-000506

Insider Transaction Report

Form 4
Period: 2019-12-16
Gwydir Tom
Director
Transactions
  • Award

    Stock Option (right to buy)

    2019-12-16+5,5685,568 total
    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
  • Award

    Common Stock

    2019-12-16+2,3652,365 total
Holdings
  • Stock Option (right to buy)

    Exercise: $5.31Exp: 2029-04-29Common Stock (9,627 underlying)
    9,627
Footnotes (3)
  • [F1]On December 16, 2019, the Company granted 2,365 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Gwydir in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
  • [F2]The option vests as to 3,209 shares on each of 4/29/19, 4/29/20 and 4/29/21.
  • [F3]On December 16, 2019, the Company granted an option to purchase 5,568 shares of common stock of the Company (the "Option") in respect of the service by Mr. Gwydir as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. The Option vests as to 1,856 shares on each of 12/16/19, 12/16/20 and 12/16/21.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001775308

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:12 PM ET
Size
9.1 KB